Circulating Carotenoids and Risk of Breast Cancer: Pooled Analysis of Eight Prospective Studies
Authors:
- A. Heather EliassenAEA. Heather Eliassen
- Sara J. HendricksonSHSara J. Hendrickson
- Louise A. BrintonLBLouise A. Brinton
- Julie E. BuringJBJulie E. Buring
- Hannia CamposHCHannia Campos
- Qi DaiQDQi Dai
- Joanne F. DorganJDJoanne F. Dorgan
- Adrian A. FrankeAFAdrian A. Franke
- Yu-Tang GaoYGYu-Tang Gao
- Marc T. GoodmanMGMarc T. Goodman
- Göran HallmansGHGöran Hallmans
- Kathy J. HelzlsouerKHKathy J. Helzlsouer
Open Access
- 18 December 2012
- journal article
- research article
- Published by Oxford University Press (OUP) in JNCI: Journal of the National Cancer Institute
- Vol. 104 (24) , 1905-1916
Abstract
Carotenoids, micronutrients in fruits and vegetables, may reduce breast cancer risk. Most, but not all, past studies of circulating carotenoids and breast cancer have found an inverse association with at least one carotenoid, although the specific carotenoid has varied across studies. We conducted a pooled analysis of eight cohort studies comprising more than 80% of the world’s published prospective data on plasma or serum carotenoids and breast cancer, including 3055 case subjects and 3956 matched control subjects. To account for laboratory differences and examine population differences across studies, we recalibrated participant carotenoid levels to a common standard by reassaying 20 plasma or serum samples from each cohort together at the same laboratory. Using conditional logistic regression, adjusting for several breast cancer risk factors, we calculated relative risks (RRs) and 95% confidence intervals (CIs) using quintiles defined among the control subjects from all studies. All P values are two-sided. Statistically significant inverse associations with breast cancer were observed for α-carotene (top vs bottom quintile RR = 0.87, 95% CI = 0.71 to 1.05, Ptrend = .04), β-carotene (RR = 0.83, 95% CI = 0.70 to 0.98, Ptrend = .02), lutein+zeaxanthin (RR = 0.84, 95% CI = 0.70 to 1.01, Ptrend = .05), lycopene (RR = 0.78, 95% CI = 0.62 to 0.99, Ptrend = .02), and total carotenoids (RR = 0.81, 95% CI = 0.68 to 0.96, Ptrend = .01). β-Cryptoxanthin was not statistically significantly associated with risk. Tests for heterogeneity across studies were not statistically significant. For several carotenoids, associations appeared stronger for estrogen receptor negative (ER−) than for ER+ tumors (eg, β-carotene: ER−: top vs bottom quintile RR = 0.52, 95% CI = 0.36 to 0.77, Ptrend = .001; ER+: RR = 0.83, 95% CI = 0.66 to 1.04, Ptrend = .06; Pheterogeneity = .01). This comprehensive prospective analysis suggests women with higher circulating levels of α-carotene, β-carotene, lutein+zeaxanthin, lycopene, and total carotenoids may be at reduced risk of breast cancer.Keywords
This publication has 66 references indexed in Scilit:
- Mammalian Carotenoid-oxygenases: Key players for carotenoid function and homeostasisBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2012
- Low-Carbohydrate Diets, Dietary Approaches to Stop Hypertension-Style Diets, and the Risk of Postmenopausal Breast CancerAmerican Journal of Epidemiology, 2011
- Dietary patterns and risk of breast cancerBritish Journal of Cancer, 2010
- Fruit and Vegetable Intake in Relation to Risk of Breast Cancer in the Black Women's Health StudyAmerican Journal of Epidemiology, 2010
- Serum carotenoid, tocopherol and retinol concentrations and breast cancer risk in the E3N‐EPIC studyInternational Journal of Cancer, 2010
- Plasma carotenoids, tocopherols, retinol and breast cancer risk: results from the Shanghai Women Health Study (SWHS)Breast Cancer Research and Treatment, 2008
- Low-Fat Dietary Pattern and Risk of Invasive Breast CancerJAMA, 2006
- Effects of a Combination of Beta Carotene and Vitamin A on Lung Cancer and Cardiovascular DiseaseNew England Journal of Medicine, 1996
- Flexible regression models with cubic splinesStatistics in Medicine, 1989
- Meta-analysis in clinical trialsControlled Clinical Trials, 1986